--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): February 14, 2005
Charles River Laboratories International, Inc.
----------------------------------
(Exact name of registrant as specified in its charter)
Delaware 001-15943 06-1397316
---------------------------- ------------- -------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
251 Ballardvale St., Wilmington,
Massachusetts 01887
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 978-658-6000
Not Applicable
---------------------------------------------------------
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
--------------------------------------------------------------------------------
Item 2.02. Results of Operations and Financial Condition.
EXPLANATORY NOTE
This Form 8-K/A (the "Form 8-K/A") is an amendment to the Current Report on Form
8-K of Charles River Laboratories International, Inc., dated February 14, 2005
(the "Form 8-K"). The purpose of the Form 8-K/A is to correct an error in the
diluted earnings per common share line item on the income statement attached to
the press release and furnished as Exhibit 99.1 to the Form 8-K. Except for
correction of this error, this Form 8-K/A does not update, modify or amend any
disclosure set forth in the Form 8-K.
Item 2.02 Results of Operations and Financial Condition
On February 14, 2005, Charles River Laboratories International, Inc. issued a
press release with respect to its earnings for the fiscal quarter and
year-to-date ended December 25, 2004, which is furnished as Exhibit 99.1 to this
Current Report on Form 8-K/A.
The information included herein and in Exhibit 99.1 shall not be deemed "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it
be deemed incorporated by reference in any filing under the Securities Act of
1933.
Item 9.01. Financial Statements and Exhibits.
c) Exhibits
Exhibit No. Exhibit Description
99.1 Press release dated February 14, 2005.
--------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Charles River Laboratories
International, Inc.
February 14, 2005 By: /s/ Jody Acford
---------------------------------
Name: Jody Acford
Title: Sr. Vice President and
General Counsel